> top > docs > PMC:3342329 > spans > 195-1688 > annotations

PMC:3342329 / 195-1688 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T99 664-668 Protein denotes CCR5
T112 1486-1492 Protein denotes IL-1Ra
T111 1470-1482 Positive_regulation denotes upregulation
T110 1446-1456 Negative_regulation denotes inhibition
T109 1382-1386 Protein denotes CCR5
T108 1331-1335 Protein denotes CCR5
T107 1298-1302 Protein denotes CCR5
T106 1138-1142 Protein denotes CCR5
T105 1100-1104 Protein denotes CCR5
T104 998-1004 Protein denotes IL-1Ra
T103 942-946 Protein denotes CCR5
T102 905-914 Negative_regulation denotes decreased
T101 893-899 Protein denotes C-IAP1
T100 709-713 Protein denotes CCR5
T98 604-619 Phosphorylation denotes phosphorylation
T97 590-600 Negative_regulation denotes inhibition
T96 570-577 Entity denotes nucleus
T95 557-560 Protein denotes p65
T94 549-552 Protein denotes p50
T93 532-545 Localization denotes translocation
T92 291-295 Protein denotes CCR5
T91 190-194 Protein denotes CCR5
T90 175-179 Protein denotes CCR5
T89 146-150 Protein denotes CCR5
T88 131-135 Protein denotes CCR5
T87 66-76 Gene_expression denotes expression
T86 60-64 Protein denotes CCR5
T85 29-58 Protein denotes C-C chemokine receptor type 5
T80 1486-1492 Protein denotes IL-1Ra
T79 1382-1386 Protein denotes CCR5
T78 1331-1335 Protein denotes CCR5
T77 1298-1302 Protein denotes CCR5
T76 1138-1142 Protein denotes CCR5
T75 1100-1104 Protein denotes CCR5
T74 998-1004 Protein denotes IL-1Ra
T73 942-946 Protein denotes CCR5
T72 893-899 Protein denotes C-IAP1
T71 709-713 Protein denotes CCR5
T70 664-668 Protein denotes CCR5
T69 557-560 Protein denotes p65
T68 549-552 Protein denotes p50
T67 291-295 Protein denotes CCR5
T66 190-194 Protein denotes CCR5
T65 175-179 Protein denotes CCR5
T64 146-150 Protein denotes CCR5
T63 131-135 Protein denotes CCR5
T62 60-64 Protein denotes CCR5
T61 29-58 Protein denotes C-C chemokine receptor type 5
R17 T85 T87 themeOf C-C chemokine receptor type 5,expression
R18 T86 T85 equivalentTo CCR5,C-C chemokine receptor type 5
R19 T94 T93 themeOf p50,translocation
R20 T95 T93 themeOf p65,translocation
R21 T96 T93 locationOf nucleus,translocation
R22 T98 T97 themeOf phosphorylation,inhibition
R23 T112 T111 themeOf IL-1Ra,upregulation

testone

Id Subject Object Predicate Lexical cue
T41 1298-1302 Protein denotes CCR5
T40 1138-1142 Protein denotes CCR5
T39 1100-1104 Protein denotes CCR5
T38 998-1004 Protein denotes IL-1Ra
T37 942-946 Protein denotes CCR5
T36 893-899 Protein denotes C-IAP1
T35 709-713 Protein denotes CCR5
T34 664-668 Protein denotes CCR5
T33 557-560 Protein denotes p65
T32 549-552 Protein denotes p50
T31 291-295 Protein denotes CCR5
T30 190-194 Protein denotes CCR5
T29 175-179 Protein denotes CCR5
T28 146-150 Protein denotes CCR5
T27 131-135 Protein denotes CCR5
T26 60-64 Protein denotes CCR5
T25 29-58 Protein denotes C-C chemokine receptor type 5
T58 1470-1482 Positive_regulation denotes upregulation
T57 1446-1456 Negative_regulation denotes inhibition
T56 1387-1397 Negative_regulation denotes deficiency
T55 905-914 Negative_regulation denotes decreased
T54 859-869 Gene_expression denotes expression
T53 774-781 Phosphorylation denotes cleaved
T52 604-619 Phosphorylation denotes phosphorylation
T51 570-577 Entity denotes nucleus
T50 532-545 Localization denotes translocation
T49 501-508 Binding denotes binding
T48 483-493 Negative_regulation denotes inhibition
T47 66-76 Gene_expression denotes expression
T44 1486-1492 Protein denotes IL-1Ra
T43 1382-1386 Protein denotes CCR5
T42 1331-1335 Protein denotes CCR5
R5 T32 T50 themeOf p50,translocation
R6 T33 T50 themeOf p65,translocation
R7 T36 T55 themeOf C-IAP1,decreased
R8 T36 T54 themeOf C-IAP1,expression
R9 T43 T56 themeOf CCR5,deficiency
R10 T44 T58 themeOf IL-1Ra,upregulation
R11 T49 T48 themeOf binding,inhibition
R12 T51 T50 locationOf nucleus,translocation
R13 T54 T55 themeOf expression,decreased
R14 T58 T57 themeOf upregulation,inhibition
R3 T25 T47 themeOf C-C chemokine receptor type 5,expression
R4 T26 T25 equivalentTo CCR5,C-C chemokine receptor type 5

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T646 1387-1397 Negative_regulation denotes deficiency
T645 1470-1482 Positive_regulation denotes upregulation
T644 1061-1069 Positive_regulation denotes elevated
T643 905-914 Negative_regulation denotes decreased
T642 859-869 Gene_expression denotes expression
T641 532-545 Localization denotes translocation
T640 66-76 Gene_expression denotes expression
T639 136-144 Negative_regulation denotes knockout
T636 1486-1492 Protein denotes IL-1Ra
T635 1382-1386 Protein denotes CCR5
T634 1331-1335 Protein denotes CCR5
T633 1298-1302 Protein denotes CCR5
T632 1138-1142 Protein denotes CCR5
T631 1100-1104 Protein denotes CCR5
T630 998-1004 Protein denotes IL-1Ra
T629 942-946 Protein denotes CCR5
T628 893-899 Protein denotes C-IAP1
T627 709-713 Protein denotes CCR5
T626 664-668 Protein denotes CCR5
T625 557-560 Protein denotes p65
T624 549-552 Protein denotes p50
T623 291-295 Protein denotes CCR5
T622 190-194 Protein denotes CCR5
T621 175-179 Protein denotes CCR5
T620 146-150 Protein denotes CCR5
T619 131-135 Protein denotes CCR5
T618 60-64 Protein denotes CCR5
T617 29-58 Protein denotes C-C chemokine receptor type 5
R338 T617 T640 themeOf C-C chemokine receptor type 5,expression
R339 T618 T640 themeOf CCR5,expression
R340 T619 T639 themeOf CCR5,knockout
R341 T620 T639 themeOf CCR5,knockout
R342 T624 T641 themeOf p50,translocation
R343 T625 T641 themeOf p65,translocation
R344 T628 T642 themeOf C-IAP1,expression
R345 T628 T643 themeOf C-IAP1,decreased
R346 T630 T644 themeOf IL-1Ra,elevated
R347 T635 T646 themeOf CCR5,deficiency
R348 T636 T645 themeOf IL-1Ra,upregulation

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T772 1387-1397 Negative_regulation denotes deficiency
T771 1470-1482 Positive_regulation denotes upregulation
T770 1061-1069 Positive_regulation denotes elevated
T769 859-869 Gene_expression denotes expression
T768 905-914 Negative_regulation denotes decreased
T767 532-545 Localization denotes translocation
T766 66-76 Gene_expression denotes expression
T765 136-144 Negative_regulation denotes knockout
T762 1486-1492 Protein denotes IL-1Ra
T761 1382-1386 Protein denotes CCR5
T760 1331-1335 Protein denotes CCR5
T759 1298-1302 Protein denotes CCR5
T758 1138-1142 Protein denotes CCR5
T757 1100-1104 Protein denotes CCR5
T756 998-1004 Protein denotes IL-1Ra
T755 942-946 Protein denotes CCR5
T754 893-899 Protein denotes C-IAP1
T753 709-713 Protein denotes CCR5
T752 664-668 Protein denotes CCR5
T751 557-560 Protein denotes p65
T750 549-552 Protein denotes p50
T749 291-295 Protein denotes CCR5
T748 190-194 Protein denotes CCR5
T747 175-179 Protein denotes CCR5
T746 146-150 Protein denotes CCR5
T745 131-135 Protein denotes CCR5
T744 60-64 Protein denotes CCR5
T743 29-58 Protein denotes C-C chemokine receptor type 5
R407 T743 T766 themeOf C-C chemokine receptor type 5,expression
R408 T744 T766 themeOf CCR5,expression
R409 T745 T765 themeOf CCR5,knockout
R410 T746 T765 themeOf CCR5,knockout
R411 T750 T767 themeOf p50,translocation
R412 T751 T767 themeOf p65,translocation
R413 T754 T769 themeOf C-IAP1,expression
R414 T754 T768 themeOf C-IAP1,decreased
R415 T756 T770 themeOf IL-1Ra,elevated
R416 T761 T772 themeOf CCR5,deficiency
R417 T762 T771 themeOf IL-1Ra,upregulation
R418 T769 T768 themeOf expression,decreased

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T530 1486-1492 NN denotes IL-1Ra
T529 1483-1485 IN denotes of
T528 1470-1482 NN denotes upregulation
T527 1466-1469 CC denotes and
T526 1460-1465 NN denotes NF-κB
T525 1457-1459 IN denotes of
T524 1446-1456 NN denotes inhibition
T523 1438-1445 IN denotes through
T522 1429-1437 NN denotes melanoma
T521 1426-1428 IN denotes of
T520 1420-1425 NN denotes death
T519 1415-1419 NN denotes cell
T518 1405-1414 JJ denotes apoptotic
T517 1398-1404 VB denotes caused
T516 1387-1397 NN denotes deficiency
T515 1382-1386 NN denotes CCR5
T514 1377-1381 IN denotes that
T513 1370-1376 VB denotes showed
T512 1362-1369 NN denotes results
T511 1356-1361 DT denotes these
T510 1354-1355 -COMMA- denotes ,
T509 1345-1354 RB denotes Therefore
T508 1339-1343 NN denotes mice
T507 1331-1338 JJ denotes CCR5+/+
T506 1328-1330 IN denotes of
T505 1323-1327 DT denotes that
T504 1320-1322 TO denotes to
T503 1311-1319 VB denotes compared
T502 1306-1310 NN denotes mice
T501 1298-1305 NN denotes CCR5−/−
T500 1295-1297 IN denotes of
T499 1288-1294 NN denotes tissue
T498 1281-1287 NN denotes spleen
T497 1277-1280 CC denotes and
T496 1271-1276 NN denotes tumor
T495 1262-1270 NN denotes melanoma
T494 1259-1261 IN denotes in
T493 1249-1258 VB denotes increased
T492 1235-1248 RB denotes significantly
T491 1231-1234 VB denotes was
T490 1225-1230 NN denotes cells
T489 1218-1224 NN denotes killer
T488 1210-1217 JJ denotes natural
T487 1204-1209 JJ denotes CD57+
T486 1200-1203 CC denotes and
T485 1195-1199 NN denotes cell
T484 1193-1194 NN denotes T
T483 1183-1192 JJ denotes cytotoxic
T482 1178-1182 JJ denotes CD8+
T481 1175-1177 IN denotes of
T480 1162-1174 NN denotes infiltration
T479 1160-1161 -COMMA- denotes ,
T478 1152-1160 RB denotes Moreover
T477 1146-1150 NN denotes mice
T476 1138-1145 JJ denotes CCR5+/+
T475 1135-1137 IN denotes in
T474 1129-1134 NN denotes level
T473 1125-1128 DT denotes the
T472 1122-1124 TO denotes to
T471 1113-1121 VB denotes compared
T470 1108-1112 NN denotes mice
T469 1100-1107 NN denotes CCR5−/−
T468 1097-1099 IN denotes of
T467 1090-1096 NN denotes spleen
T466 1086-1089 CC denotes and
T465 1079-1085 NN denotes tissue
T464 1073-1078 NN denotes tumor
T463 1070-1072 IN denotes in
T462 1061-1069 VB denotes elevated
T461 1047-1060 RB denotes significantly
T460 1043-1046 VB denotes was
T459 1041-1042 -COMMA- denotes ,
T458 1033-1041 NN denotes cytokine
T457 1021-1032 JJ denotes suppressive
T456 1014-1020 NN denotes growth
T455 1008-1013 NN denotes tumor
T454 1006-1007 DT denotes a
T453 1004-1005 -COMMA- denotes ,
T452 998-1004 NN denotes IL-1Ra
T451 995-997 IN denotes of
T450 989-994 NN denotes level
T449 985-988 DT denotes the
T448 980-984 IN denotes that
T447 974-979 VB denotes found
T446 971-973 PRP denotes we
T445 969-970 -COMMA- denotes ,
T444 956-969 RB denotes Interestingly
T443 950-954 NN denotes mice
T442 942-949 NN denotes CCR5−/−
T441 939-941 IN denotes of
T440 931-938 NN denotes tissues
T439 922-930 NN denotes melanoma
T438 918-921 DT denotes the
T301 128-130 IN denotes in
T300 121-127 NN denotes growth
T299 112-120 NN denotes melanoma
T298 103-111 VB denotes compared
T297 100-102 PRP denotes we
T296 98-99 -COMMA- denotes ,
T295 87-98 NN denotes development
T294 81-86 NN denotes tumor
T293 77-80 CC denotes and
T292 66-76 NN denotes expression
T291 64-65 -RRB- denotes )
T290 60-64 NN denotes CCR5
T289 59-60 -LRB- denotes (
T288 57-58 CD denotes 5
T287 52-56 NN denotes type
T286 43-51 NN denotes receptor
T285 33-42 NN denotes chemokine
T284 29-32 NN denotes C-C
T283 26-28 IN denotes of
T282 16-25 NN denotes relevance
T281 12-15 DT denotes the
T280 3-11 VB denotes evaluate
T279 0-2 TO denotes To
T437 915-917 IN denotes in
T436 905-914 VB denotes decreased
T435 901-904 VB denotes was
T434 899-900 -COMMA- denotes ,
T433 893-899 NN denotes C-IAP1
T432 891-892 -COMMA- denotes ,
T431 886-891 NN denotes Bcl-2
T430 883-885 IN denotes as
T429 878-882 JJ denotes such
T428 876-877 -COMMA- denotes ,
T427 870-876 NN denotes levels
T426 859-869 NN denotes expression
T425 851-858 NN denotes protein
T424 842-850 NN denotes survival
T423 838-841 DT denotes the
T422 830-837 IN denotes whereas
T421 828-829 -COMMA- denotes ,
T420 820-828 VB denotes elevated
T419 816-819 VB denotes was
T418 814-815 -COMMA- denotes ,
T417 811-814 NN denotes Bax
T416 807-810 CC denotes and
T415 805-806 -COMMA- denotes ,
T414 801-805 NN denotes PARP
T413 793-800 VB denotes cleaved
T412 791-792 -COMMA- denotes ,
T411 782-791 NN denotes caspase-3
T410 774-781 VB denotes cleaved
T409 771-773 IN denotes as
T408 766-770 JJ denotes such
T407 764-765 -COMMA- denotes ,
T406 754-764 NN denotes expression
T405 746-753 NN denotes protein
T404 736-745 JJ denotes apoptotic
T403 729-735 NN denotes target
T402 723-728 NN denotes NF-κB
T401 717-721 NN denotes mice
T400 709-716 JJ denotes CCR5+/+
T399 706-708 IN denotes of
T398 698-705 NN denotes tissues
T397 689-697 NN denotes melanoma
T396 686-688 TO denotes to
T395 677-685 VB denotes compared
T394 672-676 NN denotes mice
T393 664-671 NN denotes CCR5−/−
T392 661-663 IN denotes of
T391 653-660 NN denotes tissues
T390 644-652 NN denotes melanoma
T389 640-643 DT denotes the
T388 637-639 IN denotes in
T387 631-636 VB denotes found
T386 627-630 VB denotes was
T385 623-626 NN denotes IκB
T384 620-622 IN denotes of
T383 604-619 NN denotes phosphorylation
T382 601-603 IN denotes of
T381 590-600 NN denotes inhibition
T380 586-589 DT denotes the
T379 578-585 IN denotes through
T378 570-577 NN denotes nucleus
T377 566-569 DT denotes the
T376 561-565 IN denotes into
T375 557-560 NN denotes p65
T374 553-556 CC denotes and
T373 549-552 NN denotes p50
T372 546-548 IN denotes of
T371 532-545 NN denotes translocation
T370 528-531 CC denotes and
T369 526-527 -COMMA- denotes ,
T368 521-526 NN denotes NF-κB
T367 518-520 IN denotes of
T366 509-517 NN denotes activity
T365 501-508 NN denotes binding
T364 497-500 NN denotes DNA
T363 494-496 IN denotes of
T362 483-493 NN denotes inhibition
T361 471-482 JJ denotes Significant
T360 463-469 NN denotes growth
T359 457-462 NN denotes tumor
T358 453-456 CC denotes and
T357 451-452 -COMMA- denotes ,
T356 442-451 NN denotes apoptosis
T355 440-441 -COMMA- denotes ,
T354 434-440 NN denotes growth
T353 429-433 NN denotes cell
T352 419-428 VB denotes involving
T351 413-418 NN denotes genes
T350 410-412 IN denotes of
T349 399-409 NN denotes regulation
T348 395-398 DT denotes the
T347 392-394 IN denotes in
T346 385-391 NN denotes factor
T345 371-384 NN denotes transcription
T344 360-370 VB denotes implicated
T343 357-359 DT denotes an
T342 354-356 VB denotes is
T341 351-353 PRP denotes it
T340 345-350 IN denotes since
T339 339-344 NN denotes NF-κB
T338 336-338 IN denotes of
T337 325-335 NN denotes activation
T336 321-324 DT denotes the
T335 308-320 VB denotes investigated
T334 305-307 PRP denotes We
T333 299-303 NN denotes mice
T332 291-298 JJ denotes CCR5+/+
T331 288-290 TO denotes to
T330 279-287 VB denotes compared
T329 274-278 WRB denotes when
T328 269-273 NN denotes rate
T327 260-268 NN denotes survival
T326 250-259 VB denotes increased
T325 246-249 CC denotes and
T324 244-245 -COMMA- denotes ,
T323 238-244 NN denotes weight
T322 232-237 NN denotes tumor
T321 230-231 -COMMA- denotes ,
T320 224-230 NN denotes volume
T319 218-223 NN denotes tumor
T318 210-217 VB denotes reduced
T317 203-209 VB denotes showed
T316 198-202 NN denotes mice
T315 190-197 NN denotes CCR5−/−
T314 184-188 NN denotes mice
T313 182-183 -RRB- denotes )
T312 175-182 NN denotes CCR5+/+
T311 174-175 -LRB- denotes (
T310 169-173 NN denotes type
T309 164-168 JJ denotes wild
T308 160-163 CC denotes and
T307 155-159 NN denotes mice
T306 153-154 -RRB- denotes )
T305 146-153 NN denotes CCR5−/−
T304 145-146 -LRB- denotes (
T303 136-144 NN denotes knockout
T302 131-135 NN denotes CCR5
R61 T280 T279 arg1Of evaluate,To
R62 T282 T280 arg2Of relevance,evaluate
R63 T282 T281 arg1Of relevance,the
R64 T282 T283 arg1Of relevance,of
R65 T290 T289 arg2Of CCR5,(
R66 T291 T289 arg3Of ),(
R67 T292 T284 arg1Of expression,C-C
R68 T292 T285 arg1Of expression,chemokine
R69 T292 T286 arg1Of expression,receptor
R70 T292 T287 arg1Of expression,type
R71 T292 T288 arg1Of expression,5
R72 T292 T289 arg1Of expression,(
R73 T292 T293 arg1Of expression,and
R74 T293 T283 arg2Of and,of
R75 T295 T293 arg2Of development,and
R76 T295 T294 arg1Of development,tumor
R77 T297 T280 arg1Of we,evaluate
R78 T297 T298 arg1Of we,compared
R79 T298 T279 modOf compared,To
R80 T298 T296 arg1Of compared,","
R81 T300 T298 arg2Of growth,compared
R82 T300 T299 arg1Of growth,melanoma
R83 T300 T301 arg1Of growth,in
R84 T303 T302 arg1Of knockout,CCR5
R85 T303 T304 arg1Of knockout,(
R86 T305 T304 arg2Of CCR5−/−,(
R87 T306 T304 arg3Of ),(
R88 T307 T303 arg1Of mice,knockout
R89 T307 T308 arg1Of mice,and
R90 T308 T301 arg2Of and,in
R91 T310 T309 arg1Of type,wild
R92 T310 T311 arg1Of type,(
R93 T312 T311 arg2Of CCR5+/+,(
R94 T313 T311 arg3Of ),(
R95 T314 T308 arg2Of mice,and
R96 T314 T310 arg1Of mice,type
R97 T316 T315 arg1Of mice,CCR5−/−
R98 T316 T317 arg1Of mice,showed
R99 T316 T330 arg1Of mice,compared
R100 T317 T329 arg1Of showed,when
R101 T320 T318 arg2Of volume,reduced
R102 T320 T319 arg1Of volume,tumor
R103 T320 T321 arg1Of volume,","
R104 T321 T325 arg1Of ",",and
R105 T323 T321 arg2Of weight,","
R106 T323 T322 arg1Of weight,tumor
R107 T325 T317 arg2Of and,showed
R108 T325 T324 arg1Of and,","
R109 T328 T325 arg2Of rate,and
R110 T328 T326 arg2Of rate,increased
R111 T328 T327 arg1Of rate,survival
R112 T330 T329 arg2Of compared,when
R113 T330 T331 arg1Of compared,to
R114 T333 T331 arg2Of mice,to
R115 T333 T332 arg1Of mice,CCR5+/+
R116 T334 T335 arg1Of We,investigated
R117 T335 T340 arg1Of investigated,since
R118 T337 T335 arg2Of activation,investigated
R119 T337 T336 arg1Of activation,the
R120 T337 T338 arg1Of activation,of
R121 T339 T338 arg2Of NF-κB,of
R122 T341 T342 arg1Of it,is
R123 T342 T340 arg2Of is,since
R124 T346 T342 arg2Of factor,is
R125 T346 T343 arg1Of factor,an
R126 T346 T344 arg2Of factor,implicated
R127 T346 T345 arg1Of factor,transcription
R128 T346 T347 arg1Of factor,in
R129 T349 T347 arg2Of regulation,in
R130 T349 T348 arg1Of regulation,the
R131 T349 T350 arg1Of regulation,of
R132 T351 T350 arg2Of genes,of
R133 T351 T352 arg1Of genes,involving
R134 T354 T353 arg1Of growth,cell
R135 T354 T355 arg1Of growth,","
R136 T355 T358 arg1Of ",",and
R137 T356 T355 arg2Of apoptosis,","
R138 T358 T352 arg2Of and,involving
R139 T358 T357 arg1Of and,","
R140 T360 T358 arg2Of growth,and
R141 T360 T359 arg1Of growth,tumor
R142 T362 T361 arg1Of inhibition,Significant
R143 T362 T363 arg1Of inhibition,of
R144 T362 T370 arg1Of inhibition,and
R145 T366 T363 arg2Of activity,of
R146 T366 T364 arg1Of activity,DNA
R147 T366 T365 arg1Of activity,binding
R148 T366 T367 arg1Of activity,of
R149 T368 T367 arg2Of NF-κB,of
R150 T370 T369 arg1Of and,","
R151 T370 T379 arg1Of and,through
R152 T370 T386 arg1Of and,was
R153 T370 T387 arg2Of and,found
R154 T371 T370 arg2Of translocation,and
R155 T371 T372 arg1Of translocation,of
R156 T371 T376 arg1Of translocation,into
R157 T373 T374 arg1Of p50,and
R158 T374 T372 arg2Of and,of
R159 T375 T374 arg2Of p65,and
R160 T378 T376 arg2Of nucleus,into
R161 T378 T377 arg1Of nucleus,the
R162 T381 T379 arg2Of inhibition,through
R163 T381 T380 arg1Of inhibition,the
R164 T381 T382 arg1Of inhibition,of
R165 T383 T382 arg2Of phosphorylation,of
R166 T383 T384 arg1Of phosphorylation,of
R167 T385 T384 arg2Of IκB,of
R168 T387 T386 arg2Of found,was
R169 T387 T388 arg1Of found,in
R170 T387 T395 arg1Of found,compared
R171 T391 T388 arg2Of tissues,in
R172 T391 T389 arg1Of tissues,the
R173 T391 T390 arg1Of tissues,melanoma
R174 T391 T392 arg1Of tissues,of
R175 T394 T392 arg2Of mice,of
R176 T394 T393 arg1Of mice,CCR5−/−
R177 T396 T395 arg2Of to,compared
R178 T398 T396 arg2Of tissues,to
R179 T398 T397 arg1Of tissues,melanoma
R180 T398 T399 arg1Of tissues,of
R181 T401 T399 arg2Of mice,of
R182 T401 T400 arg1Of mice,CCR5+/+
R183 T406 T402 arg1Of expression,NF-κB
R184 T406 T403 arg1Of expression,target
R185 T406 T404 arg1Of expression,apoptotic
R186 T406 T405 arg1Of expression,protein
R187 T406 T407 arg1Of expression,","
R188 T406 T409 arg1Of expression,as
R189 T406 T419 arg1Of expression,was
R190 T406 T420 arg2Of expression,elevated
R191 T409 T408 arg1Of as,such
R192 T411 T410 arg2Of caspase-3,cleaved
R193 T411 T413 arg2Of caspase-3,cleaved
R194 T411 T416 arg1Of caspase-3,and
R195 T413 T412 arg1Of cleaved,","
R196 T414 T413 arg3Of PARP,cleaved
R197 T416 T409 arg2Of and,as
R198 T416 T415 arg1Of and,","
R199 T417 T416 arg2Of Bax,and
R200 T420 T418 arg1Of elevated,","
R201 T420 T419 arg2Of elevated,was
R202 T420 T421 arg1Of elevated,","
R203 T420 T422 arg1Of elevated,whereas
R204 T427 T423 arg1Of levels,the
R205 T427 T424 arg1Of levels,survival
R206 T427 T425 arg1Of levels,protein
R207 T427 T426 arg1Of levels,expression
R208 T427 T428 arg1Of levels,","
R209 T427 T430 arg1Of levels,as
R210 T427 T435 arg1Of levels,was
R211 T427 T436 arg2Of levels,decreased
R212 T430 T429 arg1Of as,such
R213 T431 T430 arg2Of Bcl-2,as
R214 T431 T432 arg1Of Bcl-2,","
R215 T433 T432 arg2Of C-IAP1,","
R216 T436 T422 arg2Of decreased,whereas
R217 T436 T434 arg1Of decreased,","
R218 T436 T435 arg2Of decreased,was
R219 T436 T437 arg1Of decreased,in
R220 T440 T437 arg2Of tissues,in
R221 T440 T438 arg1Of tissues,the
R222 T440 T439 arg1Of tissues,melanoma
R223 T440 T441 arg1Of tissues,of
R224 T443 T441 arg2Of mice,of
R225 T443 T442 arg1Of mice,CCR5−/−
R226 T446 T447 arg1Of we,found
R227 T447 T444 arg1Of found,Interestingly
R228 T447 T445 arg1Of found,","
R229 T450 T449 arg1Of level,the
R230 T450 T451 arg1Of level,of
R231 T450 T453 arg1Of level,","
R232 T450 T460 arg1Of level,was
R233 T450 T462 arg2Of level,elevated
R234 T452 T451 arg2Of IL-1Ra,of
R235 T458 T453 arg2Of cytokine,","
R236 T458 T454 arg1Of cytokine,a
R237 T458 T455 arg1Of cytokine,tumor
R238 T458 T456 arg1Of cytokine,growth
R239 T458 T457 arg1Of cytokine,suppressive
R240 T462 T447 arg2Of elevated,found
R241 T462 T448 arg1Of elevated,that
R242 T462 T459 arg1Of elevated,","
R243 T462 T460 arg2Of elevated,was
R244 T462 T461 arg1Of elevated,significantly
R245 T462 T463 arg1Of elevated,in
R246 T465 T464 arg1Of tissue,tumor
R247 T465 T466 arg1Of tissue,and
R248 T466 T463 arg2Of and,in
R249 T466 T471 arg1Of and,compared
R250 T467 T466 arg2Of spleen,and
R251 T467 T468 arg1Of spleen,of
R252 T470 T468 arg2Of mice,of
R253 T470 T469 arg1Of mice,CCR5−/−
R254 T472 T471 arg2Of to,compared
R255 T474 T472 arg2Of level,to
R256 T474 T473 arg1Of level,the
R257 T474 T475 arg1Of level,in
R258 T477 T475 arg2Of mice,in
R259 T477 T476 arg1Of mice,CCR5+/+
R260 T480 T481 arg1Of infiltration,of
R261 T480 T491 arg1Of infiltration,was
R262 T480 T493 arg2Of infiltration,increased
R263 T485 T482 arg1Of cell,CD8+
R264 T485 T483 arg1Of cell,cytotoxic
R265 T485 T484 arg1Of cell,T
R266 T485 T486 arg1Of cell,and
R267 T486 T481 arg2Of and,of
R268 T490 T486 arg2Of cells,and
R269 T490 T487 arg1Of cells,CD57+
R270 T490 T488 arg1Of cells,natural
R271 T490 T489 arg1Of cells,killer
R272 T493 T478 arg1Of increased,Moreover
R273 T493 T479 arg1Of increased,","
R274 T493 T491 arg2Of increased,was
R275 T493 T492 arg1Of increased,significantly
R276 T493 T494 arg1Of increased,in
R277 T496 T497 arg1Of tumor,and
R278 T498 T497 arg2Of spleen,and
R279 T499 T494 arg2Of tissue,in
R280 T499 T495 arg1Of tissue,melanoma
R281 T499 T496 arg1Of tissue,tumor
R282 T499 T498 arg1Of tissue,spleen
R283 T499 T500 arg1Of tissue,of
R284 T502 T500 arg2Of mice,of
R285 T502 T501 arg1Of mice,CCR5−/−
R286 T502 T503 arg2Of mice,compared
R287 T503 T504 arg1Of compared,to
R288 T505 T504 arg2Of that,to
R289 T505 T506 arg1Of that,of
R290 T508 T506 arg2Of mice,of
R291 T508 T507 arg1Of mice,CCR5+/+
R292 T512 T511 arg1Of results,these
R293 T512 T513 arg1Of results,showed
R294 T513 T509 arg1Of showed,Therefore
R295 T513 T510 arg1Of showed,","
R296 T516 T515 arg1Of deficiency,CCR5
R297 T516 T517 arg1Of deficiency,caused
R298 T517 T513 arg2Of caused,showed
R299 T517 T514 arg1Of caused,that
R300 T517 T523 arg1Of caused,through
R301 T520 T517 arg2Of death,caused
R302 T520 T518 arg1Of death,apoptotic
R303 T520 T519 arg1Of death,cell
R304 T520 T521 arg1Of death,of
R305 T522 T521 arg2Of melanoma,of
R306 T524 T523 arg2Of inhibition,through
R307 T524 T525 arg1Of inhibition,of
R308 T526 T527 arg1Of NF-κB,and
R309 T527 T525 arg2Of and,of
R310 T528 T527 arg2Of upregulation,and
R311 T528 T529 arg1Of upregulation,of
R312 T530 T529 arg2Of IL-1Ra,of

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T186 1486-1492 Protein denotes IL-1Ra
T185 1382-1386 Protein denotes CCR5
T184 1331-1335 Protein denotes CCR5
T183 1298-1302 Protein denotes CCR5
T182 1138-1142 Protein denotes CCR5
T181 1100-1104 Protein denotes CCR5
T180 998-1004 Protein denotes IL-1Ra
T179 942-946 Protein denotes CCR5
T178 893-899 Protein denotes C-IAP1
T177 709-713 Protein denotes CCR5
T176 664-668 Protein denotes CCR5
T175 557-560 Protein denotes p65
T174 549-552 Protein denotes p50
T173 291-295 Protein denotes CCR5
T172 190-194 Protein denotes CCR5
T171 175-179 Protein denotes CCR5
T170 146-150 Protein denotes CCR5
T169 131-135 Protein denotes CCR5
T168 60-64 Protein denotes CCR5
T167 29-58 Protein denotes C-C chemokine receptor type 5

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T554 1178-1181 http://www.uniprot.org/uniprot/P10966 denotes CD8
T553 1178-1181 http://www.uniprot.org/uniprot/P01732 denotes CD8
T552 893-899 http://www.uniprot.org/uniprot/Q13490 denotes C-IAP1
T551 782-791 http://www.uniprot.org/uniprot/P42574 denotes caspase-3
T550 557-560 http://www.uniprot.org/uniprot/P21579 denotes p65
T549 557-560 http://www.uniprot.org/uniprot/Q04206 denotes p65
T548 549-552 http://www.uniprot.org/uniprot/P19838 denotes p50
T547 1382-1386 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T546 1331-1335 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T545 1298-1302 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T544 1138-1142 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T543 1100-1104 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T542 942-946 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T541 709-713 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T540 664-668 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T539 291-295 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T538 190-194 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T537 175-179 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T536 146-150 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T535 131-135 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T534 60-64 http://www.uniprot.org/uniprot/P51681 denotes CCR5
T533 1486-1492 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra
T532 998-1004 http://www.uniprot.org/uniprot/P18510 denotes IL-1Ra

UBERON-AE

Id Subject Object Predicate Lexical cue
T119 1281-1287 http://purl.obolibrary.org/obo/UBERON_0002106 denotes spleen
T118 1090-1096 http://purl.obolibrary.org/obo/UBERON_0002106 denotes spleen
T117 1288-1294 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T116 1079-1085 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T115 931-938 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T114 698-705 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues
T113 653-660 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissues

GO-BP

Id Subject Object Predicate Lexical cue
T209 1420-1425 http://purl.obolibrary.org/obo/GO_0016265 denotes death
T208 1415-1425 http://purl.obolibrary.org/obo/GO_0008219 denotes cell death
T207 604-626 http://purl.obolibrary.org/obo/GO_0007252 denotes phosphorylation of IκB
T206 604-619 http://purl.obolibrary.org/obo/GO_0016310 denotes phosphorylation
T205 590-626 http://purl.obolibrary.org/obo/GO_1903720 denotes inhibition of phosphorylation of IκB
T204 590-619 http://purl.obolibrary.org/obo/GO_0042326 denotes inhibition of phosphorylation
T203 483-508 http://purl.obolibrary.org/obo/GO_0039568 denotes inhibition of DNA binding
T202 483-508 http://purl.obolibrary.org/obo/GO_1904743 denotes inhibition of DNA binding
T201 483-508 http://purl.obolibrary.org/obo/GO_0043392 denotes inhibition of DNA binding
T200 442-451 http://purl.obolibrary.org/obo/GO_0097194 denotes apoptosis
T199 1405-1425 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptotic cell death
T198 442-451 http://purl.obolibrary.org/obo/GO_0006915 denotes apoptosis
T197 429-440 http://purl.obolibrary.org/obo/GO_0016049 denotes cell growth
T196 399-409 http://purl.obolibrary.org/obo/GO_0065007 denotes regulation
T195 371-409 http://purl.obolibrary.org/obo/GO_0051090 denotes transcription factor in the regulation
T194 371-409 http://purl.obolibrary.org/obo/GO_1901483 denotes transcription factor in the regulation
T193 371-384 http://purl.obolibrary.org/obo/GO_0006351 denotes transcription
T192 325-344 http://purl.obolibrary.org/obo/GO_0051092 denotes activation of NF-κB
T191 1014-1020 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T190 463-469 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T189 434-440 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T188 121-127 http://purl.obolibrary.org/obo/GO_0040007 denotes growth
T187 87-98 http://purl.obolibrary.org/obo/GO_0032502 denotes development

GO-MF

Id Subject Object Predicate Lexical cue
T214 497-508 http://purl.obolibrary.org/obo/GO_0003677 denotes DNA binding
T215 501-508 http://purl.obolibrary.org/obo/GO_0005488 denotes binding

GO-CC

Id Subject Object Predicate Lexical cue
T210 429-433 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T211 1195-1199 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T212 1415-1419 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T213 570-577 http://purl.obolibrary.org/obo/GO_0005634 denotes nucleus

sentences

Id Subject Object Predicate Lexical cue
T128 1345-1493 Sentence denotes Therefore, these results showed that CCR5 deficiency caused apoptotic cell death of melanoma through inhibition of NF-κB and upregulation of IL-1Ra.
T127 1152-1344 Sentence denotes Moreover, infiltration of CD8+ cytotoxic T cell and CD57+ natural killer cells was significantly increased in melanoma tumor and spleen tissue of CCR5−/− mice compared to that of CCR5+/+ mice.
T126 956-1151 Sentence denotes Interestingly, we found that the level of IL-1Ra, a tumor growth suppressive cytokine, was significantly elevated in tumor tissue and spleen of CCR5−/− mice compared to the level in CCR5+/+ mice.
T125 723-955 Sentence denotes NF-κB target apoptotic protein expression, such as cleaved caspase-3, cleaved PARP, and Bax, was elevated, whereas the survival protein expression levels, such as Bcl-2, C-IAP1, was decreased in the melanoma tissues of CCR5−/− mice.
T124 471-722 Sentence denotes Significant inhibition of DNA binding activity of NF-κB, and translocation of p50 and p65 into the nucleus through the inhibition of phosphorylation of IκB was found in the melanoma tissues of CCR5−/− mice compared to melanoma tissues of CCR5+/+ mice.
T123 305-470 Sentence denotes We investigated the activation of NF-κB since it is an implicated transcription factor in the regulation of genes involving cell growth, apoptosis, and tumor growth.
T122 190-304 Sentence denotes CCR5−/− mice showed reduced tumor volume, tumor weight, and increased survival rate when compared to CCR5+/+ mice.
T121 0-189 Sentence denotes To evaluate the relevance of C-C chemokine receptor type 5 (CCR5) expression and tumor development, we compared melanoma growth in CCR5 knockout (CCR5−/−) mice and wild type (CCR5+/+) mice.
T4 0-189 Sentence denotes To evaluate the relevance of C-C chemokine receptor type 5 (CCR5) expression and tumor development, we compared melanoma growth in CCR5 knockout (CCR5−/−) mice and wild type (CCR5+/+) mice.
T5 190-304 Sentence denotes CCR5−/− mice showed reduced tumor volume, tumor weight, and increased survival rate when compared to CCR5+/+ mice.
T6 305-470 Sentence denotes We investigated the activation of NF-κB since it is an implicated transcription factor in the regulation of genes involving cell growth, apoptosis, and tumor growth.
T7 471-722 Sentence denotes Significant inhibition of DNA binding activity of NF-κB, and translocation of p50 and p65 into the nucleus through the inhibition of phosphorylation of IκB was found in the melanoma tissues of CCR5−/− mice compared to melanoma tissues of CCR5+/+ mice.
T8 723-955 Sentence denotes NF-κB target apoptotic protein expression, such as cleaved caspase-3, cleaved PARP, and Bax, was elevated, whereas the survival protein expression levels, such as Bcl-2, C-IAP1, was decreased in the melanoma tissues of CCR5−/− mice.
T9 956-1151 Sentence denotes Interestingly, we found that the level of IL-1Ra, a tumor growth suppressive cytokine, was significantly elevated in tumor tissue and spleen of CCR5−/− mice compared to the level in CCR5+/+ mice.
T10 1152-1344 Sentence denotes Moreover, infiltration of CD8+ cytotoxic T cell and CD57+ natural killer cells was significantly increased in melanoma tumor and spleen tissue of CCR5−/− mice compared to that of CCR5+/+ mice.
T11 1345-1493 Sentence denotes Therefore, these results showed that CCR5 deficiency caused apoptotic cell death of melanoma through inhibition of NF-κB and upregulation of IL-1Ra.

simple1

Id Subject Object Predicate Lexical cue
T259 1486-1492 Protein denotes IL-1Ra
T258 1382-1386 Protein denotes CCR5
T257 1331-1335 Protein denotes CCR5
T256 1298-1302 Protein denotes CCR5
T255 1138-1142 Protein denotes CCR5
T254 1100-1104 Protein denotes CCR5
T253 998-1004 Protein denotes IL-1Ra
T252 942-946 Protein denotes CCR5
T251 893-899 Protein denotes C-IAP1
T250 709-713 Protein denotes CCR5
T249 664-668 Protein denotes CCR5
T248 557-560 Protein denotes p65
T247 549-552 Protein denotes p50
T246 291-295 Protein denotes CCR5
T245 190-194 Protein denotes CCR5
T244 175-179 Protein denotes CCR5
T243 146-150 Protein denotes CCR5
T242 131-135 Protein denotes CCR5
T241 60-64 Protein denotes CCR5
T240 29-58 Protein denotes C-C chemokine receptor type 5

DLUT931

Id Subject Object Predicate Lexical cue
T587 1446-1456 Negative_regulation denotes inhibition
T586 1470-1482 Positive_regulation denotes upregulation
T585 1387-1397 Negative_regulation denotes deficiency
T584 1061-1069 Positive_regulation denotes elevated
T583 905-914 Negative_regulation denotes decreased
T582 859-869 Gene_expression denotes expression
T581 590-600 Negative_regulation denotes inhibition
T580 532-545 Localization denotes translocation
T579 136-144 Negative_regulation denotes knockout
T578 66-76 Gene_expression denotes expression
T576 1486-1492 Protein denotes IL-1Ra
T575 1382-1386 Protein denotes CCR5
T574 1331-1335 Protein denotes CCR5
T573 1298-1302 Protein denotes CCR5
T572 1138-1142 Protein denotes CCR5
T571 1100-1104 Protein denotes CCR5
T570 998-1004 Protein denotes IL-1Ra
T569 942-946 Protein denotes CCR5
T568 893-899 Protein denotes C-IAP1
T567 709-713 Protein denotes CCR5
T566 664-668 Protein denotes CCR5
T565 557-560 Protein denotes p65
T564 549-552 Protein denotes p50
T563 291-295 Protein denotes CCR5
T562 190-194 Protein denotes CCR5
T561 175-179 Protein denotes CCR5
T560 146-150 Protein denotes CCR5
T559 131-135 Protein denotes CCR5
T558 60-64 Protein denotes CCR5
T557 29-58 Protein denotes C-C chemokine receptor type 5
R314 T557 T578 themeOf C-C chemokine receptor type 5,expression
R315 T558 T578 themeOf CCR5,expression
R316 T559 T579 themeOf CCR5,knockout
R317 T560 T579 themeOf CCR5,knockout
R318 T564 T580 themeOf p50,translocation
R319 T565 T580 themeOf p65,translocation
R320 T568 T582 themeOf C-IAP1,expression
R321 T570 T584 themeOf IL-1Ra,elevated
R322 T575 T585 themeOf CCR5,deficiency
R323 T576 T586 themeOf IL-1Ra,upregulation
R324 T580 T581 themeOf translocation,inhibition
R325 T580 T581 themeOf translocation,inhibition
R326 T582 T583 themeOf expression,decreased
R327 T585 T586 causeOf deficiency,upregulation
R328 T585 T587 causeOf deficiency,inhibition
R329 T586 T587 themeOf upregulation,inhibition

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T819 774-806 Protein_catabolism denotes cleaved caspase-3, cleaved PARP,
T817 395-469 Regulation denotes the regulation of genes involving cell growth, apoptosis, and tumor growth
T816 851-869 Gene_expression denotes protein expression
T815 1470-1492 Positive_regulation denotes upregulation of IL-1Ra
T814 305-384 Positive_regulation denotes We investigated the activation of NF-κB since it is an implicated transcription
T813 851-858 Protein denotes protein
T812 950-954 Protein denotes mice
T811 886-891 Protein denotes Bcl-2
T810 723-728 Protein denotes NF-κB
T809 60-64 Protein denotes CCR5
T808 717-721 Protein denotes mice
T807 1483-1492 Protein denotes of IL-1Ra
T806 893-900 Protein denotes C-IAP1,
T805 801-805 Protein denotes PARP
T804 1033-1042 Protein denotes cytokine,
T803 1339-1343 Protein denotes mice
T802 288-303 Protein denotes to CCR5+/+ mice
T801 672-676 Protein denotes mice
T800 155-159 Protein denotes mice
T799 811-814 Protein denotes Bax
T798 998-1005 Protein denotes IL-1Ra,
T797 336-344 Protein denotes of NF-κB
T796 155-188 Protein denotes mice and wild type (CCR5+/+) mice
T795 774-806 Protein denotes cleaved caspase-3, cleaved PARP,
T794 198-202 Protein denotes mice
T793 1108-1112 Protein denotes mice
T792 1146-1150 Protein denotes mice
T791 557-560 Protein denotes p65
T790 33-42 Protein denotes chemokine
T789 1331-1335 Protein denotes CCR5
T788 1460-1465 Protein denotes NF-κB
T787 52-65 Protein denotes type 5 (CCR5)
T786 131-135 Protein denotes CCR5
T785 1306-1310 Protein denotes mice
T784 1138-1142 Protein denotes CCR5
T783 1204-1230 Entity denotes CD57+ natural killer cells
T782 746-753 Protein denotes protein
T781 1382-1397 Protein denotes CCR5 deficiency
T780 566-577 Entity denotes the nucleus
T778 410-469 Protein denotes of genes involving cell growth, apoptosis, and tumor growth
T777 518-526 Protein denotes of NF-κB
T776 1178-1199 Entity denotes CD8+ cytotoxic T cell
T775 549-552 Protein denotes p50
T773 29-76 Protein denotes C-C chemokine receptor type 5 (CCR5) expression
R419 T778 T817 themeOf "of genes involving cell growth, apoptosis, and tumor growth","the regulation of genes involving cell growth, apoptosis, and tumor growth"
R421 T795 T819 themeOf "cleaved caspase-3, cleaved PARP,","cleaved caspase-3, cleaved PARP,"
R422 T797 T814 themeOf of NF-κB,We investigated the activation of NF-κB since it is an implicated transcription
R423 T807 T815 themeOf of IL-1Ra,upregulation of IL-1Ra
R424 T813 T816 themeOf protein,protein expression

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T1066 1135-1137 IN denotes in
T1065 1129-1134 NN denotes level
T1064 1125-1128 DT denotes the
T1063 1122-1124 TO denotes to
T1062 1113-1121 VBN denotes compared
T1061 1108-1112 NNS denotes mice
T1060 1106-1107 NN denotes −
T1059 1105-1106 NN denotes /
T1058 1104-1105 CD denotes −
T1057 1100-1104 CD denotes CCR5
T1056 1097-1099 IN denotes of
T1055 1090-1096 NN denotes spleen
T1054 1086-1089 CC denotes and
T1053 1079-1085 NN denotes tissue
T1052 1073-1078 NN denotes tumor
T1051 1070-1072 IN denotes in
T1050 1061-1069 VBN denotes elevated
T1049 1047-1060 RB denotes significantly
T1048 1043-1046 VBD denotes was
T1047 1041-1042 , denotes ,
T1046 1033-1041 NN denotes cytokine
T1045 1021-1032 JJ denotes suppressive
T1044 1014-1020 NN denotes growth
T1043 1008-1013 NN denotes tumor
T1042 1006-1007 DT denotes a
T1041 1004-1005 , denotes ,
T1040 998-1004 NN denotes IL-1Ra
T1039 995-997 IN denotes of
T1038 989-994 NN denotes level
T1037 985-988 DT denotes the
T1036 980-984 IN denotes that
T1035 974-979 VBD denotes found
T1034 971-973 PRP denotes we
T1033 969-970 , denotes ,
T1032 956-969 RB denotes Interestingly
T1031 954-955 . denotes .
T1030 950-954 NNS denotes mice
T1029 948-949 NN denotes −
T1028 947-948 NN denotes /
T1027 946-947 CD denotes −
T1026 942-946 CD denotes CCR5
T1025 939-941 IN denotes of
T1024 931-938 NNS denotes tissues
T1023 922-930 NN denotes melanoma
T1022 918-921 DT denotes the
T1021 915-917 IN denotes in
T1020 905-914 VBN denotes decreased
T1019 901-904 VBD denotes was
T1018 899-900 , denotes ,
T1017 893-899 NNP denotes C-IAP1
T1016 891-892 , denotes ,
T1015 886-891 NN denotes Bcl-2
T1014 883-885 IN denotes as
T1013 878-882 JJ denotes such
T1012 876-877 , denotes ,
T1011 870-876 NNS denotes levels
T1010 859-869 NN denotes expression
T1009 851-858 NN denotes protein
T1008 842-850 NN denotes survival
T1007 838-841 DT denotes the
T1006 830-837 IN denotes whereas
T1005 828-829 , denotes ,
T1004 820-828 VBN denotes elevated
T1003 816-819 VBD denotes was
T1002 814-815 , denotes ,
T1001 811-814 NNP denotes Bax
T1000 807-810 CC denotes and
T999 805-806 , denotes ,
T998 801-805 NNP denotes PARP
T997 793-800 JJ denotes cleaved
T996 791-792 , denotes ,
T995 782-791 JJ denotes caspase-3
T994 774-781 JJ denotes cleaved
T993 771-773 IN denotes as
T992 766-770 JJ denotes such
T991 764-765 , denotes ,
T990 754-764 NN denotes expression
T989 746-753 NN denotes protein
T988 736-745 JJ denotes apoptotic
T987 729-735 NN denotes target
T986 723-728 JJ denotes NF-κB
T985 721-722 . denotes .
T984 717-721 NNS denotes mice
T983 715-716 NN denotes +
T982 714-715 NN denotes /
T981 713-714 CD denotes +
T980 709-713 CD denotes CCR5
T979 706-708 IN denotes of
T978 698-705 NNS denotes tissues
T977 689-697 VB denotes melanoma
T976 686-688 TO denotes to
T975 677-685 VBN denotes compared
T974 672-676 NNS denotes mice
T973 670-671 NN denotes −
T972 669-670 NN denotes /
T971 668-669 CD denotes −
T970 664-668 CD denotes CCR5
T969 661-663 IN denotes of
T968 653-660 NNS denotes tissues
T967 644-652 NN denotes melanoma
T966 640-643 DT denotes the
T965 637-639 IN denotes in
T964 631-636 VBN denotes found
T963 627-630 VBD denotes was
T962 623-626 NNP denotes IκB
T961 620-622 IN denotes of
T960 604-619 NN denotes phosphorylation
T959 601-603 IN denotes of
T958 590-600 NN denotes inhibition
T957 586-589 DT denotes the
T956 578-585 IN denotes through
T955 570-577 NN denotes nucleus
T954 566-569 DT denotes the
T953 561-565 IN denotes into
T952 557-560 CD denotes p65
T951 553-556 CC denotes and
T950 549-552 CD denotes p50
T949 546-548 IN denotes of
T948 532-545 NN denotes translocation
T947 528-531 CC denotes and
T946 526-527 , denotes ,
T945 521-526 NNP denotes NF-κB
T944 518-520 IN denotes of
T943 509-517 NN denotes activity
T942 501-508 JJ denotes binding
T941 497-500 NNP denotes DNA
T940 494-496 IN denotes of
T939 483-493 NN denotes inhibition
T938 471-482 JJ denotes Significant
T937 469-470 . denotes .
T936 463-469 NN denotes growth
T935 457-462 NN denotes tumor
T934 453-456 CC denotes and
T933 451-452 , denotes ,
T932 442-451 NN denotes apoptosis
T931 440-441 , denotes ,
T930 434-440 NN denotes growth
T929 429-433 NN denotes cell
T928 419-428 VBG denotes involving
T927 413-418 NNS denotes genes
T926 410-412 IN denotes of
T925 399-409 NN denotes regulation
T924 395-398 DT denotes the
T923 392-394 IN denotes in
T922 385-391 NN denotes factor
T921 371-384 NN denotes transcription
T920 360-370 VBN denotes implicated
T919 357-359 DT denotes an
T918 354-356 VBZ denotes is
T917 351-353 PRP denotes it
T916 345-350 IN denotes since
T915 339-344 NN denotes NF-κB
T914 336-338 IN denotes of
T913 325-335 NN denotes activation
T912 321-324 DT denotes the
T911 308-320 VBD denotes investigated
T910 305-307 PRP denotes We
T909 303-304 . denotes .
T908 299-303 NNS denotes mice
T907 297-298 NN denotes +
T906 296-297 NN denotes /
T905 295-296 CD denotes +
T904 291-295 CD denotes CCR5
T903 288-290 TO denotes to
T902 279-287 VBN denotes compared
T901 274-278 WRB denotes when
T900 269-273 NN denotes rate
T899 260-268 NN denotes survival
T898 250-259 VBD denotes increased
T897 246-249 CC denotes and
T896 244-245 , denotes ,
T895 238-244 NN denotes weight
T894 232-237 NN denotes tumor
T893 230-231 , denotes ,
T892 224-230 NN denotes volume
T891 218-223 NN denotes tumor
T890 210-217 VBN denotes reduced
T889 203-209 VBD denotes showed
T888 198-202 NNS denotes mice
T887 196-197 NN denotes −
T886 195-196 NN denotes /
T885 194-195 CD denotes −
T884 190-194 CD denotes CCR5
T883 188-189 . denotes .
T882 184-188 NNS denotes mice
T881 182-183 -RRB- denotes )
T880 181-182 NN denotes +
T879 180-181 NN denotes /
T878 179-180 CD denotes +
T877 175-179 CD denotes CCR5
T876 174-175 -LRB- denotes (
T875 169-173 NN denotes type
T874 164-168 JJ denotes wild
T873 160-163 CC denotes and
T872 155-159 NNS denotes mice
T871 153-154 -RRB- denotes )
T870 152-153 NN denotes −
T869 151-152 NN denotes /
T868 150-151 CD denotes −
T867 146-150 CD denotes CCR5
T866 145-146 -LRB- denotes (
T865 136-144 NN denotes knockout
T864 131-135 CD denotes CCR5
T863 128-130 IN denotes in
T862 121-127 NN denotes growth
T861 112-120 NN denotes melanoma
T860 103-111 VBD denotes compared
T859 100-102 PRP denotes we
T858 98-99 , denotes ,
T857 87-98 NN denotes development
T856 81-86 NN denotes tumor
T855 77-80 CC denotes and
T854 66-76 NN denotes expression
T853 64-65 -RRB- denotes )
T852 60-64 NNS denotes CCR5
T851 59-60 -LRB- denotes (
T1135 1492-1493 . denotes .
T1134 1486-1492 NN denotes IL-1Ra
T1133 1483-1485 IN denotes of
T1132 1470-1482 NN denotes upregulation
T1131 1466-1469 CC denotes and
T1130 1460-1465 NNP denotes NF-κB
T1129 1457-1459 IN denotes of
T1128 1446-1456 NN denotes inhibition
T1127 1438-1445 IN denotes through
T1126 1429-1437 NN denotes melanoma
T1125 1426-1428 IN denotes of
T1124 1420-1425 NN denotes death
T1123 1415-1419 NN denotes cell
T1122 1405-1414 JJ denotes apoptotic
T1121 1398-1404 VBD denotes caused
T1120 1387-1397 NN denotes deficiency
T1119 1382-1386 CD denotes CCR5
T1118 1377-1381 IN denotes that
T1117 1370-1376 VBD denotes showed
T1116 1362-1369 NNS denotes results
T1115 1356-1361 DT denotes these
T1114 1354-1355 , denotes ,
T1113 1345-1354 RB denotes Therefore
T1112 1343-1344 . denotes .
T1111 1339-1343 NNS denotes mice
T1110 1337-1338 NN denotes +
T1109 1336-1337 NN denotes /
T1108 1335-1336 CD denotes +
T1107 1331-1335 CD denotes CCR5
T1106 1328-1330 IN denotes of
T1105 1323-1327 DT denotes that
T1104 1320-1322 TO denotes to
T1103 1311-1319 VBN denotes compared
T1102 1306-1310 NNS denotes mice
T1101 1304-1305 NN denotes −
T1100 1303-1304 NN denotes /
T1099 1302-1303 CD denotes −
T1098 1298-1302 CD denotes CCR5
T1097 1295-1297 IN denotes of
T1096 1288-1294 NN denotes tissue
T1095 1281-1287 NN denotes spleen
T1094 1277-1280 CC denotes and
T1093 1271-1276 NN denotes tumor
T1092 1262-1270 NN denotes melanoma
T1091 1259-1261 IN denotes in
T1090 1249-1258 VBN denotes increased
T1089 1235-1248 RB denotes significantly
T1088 1231-1234 VBD denotes was
T1087 1225-1230 NNS denotes cells
T1086 1218-1224 NN denotes killer
T1085 1210-1217 JJ denotes natural
T1084 1208-1209 VBP denotes +
T1083 1204-1208 NNP denotes CD57
T1082 1200-1203 CC denotes and
T1081 1195-1199 NN denotes cell
T1080 1193-1194 NNP denotes T
T1079 1183-1192 JJ denotes cytotoxic
T1078 1181-1182 CD denotes +
T1077 1178-1181 CD denotes CD8
T1076 1175-1177 IN denotes of
T1075 1162-1174 NN denotes infiltration
T1074 1160-1161 , denotes ,
T1073 1152-1160 RB denotes Moreover
T1072 1150-1151 . denotes .
T1071 1146-1150 NNS denotes mice
T1070 1144-1145 NN denotes +
T1069 1143-1144 NN denotes /
T1068 1142-1143 CD denotes +
T1067 1138-1142 CD denotes CCR5
T843 12-15 DT denotes the
T842 3-11 VB denotes evaluate
T841 0-2 TO denotes To
T850 57-58 CD denotes 5
T849 52-56 NN denotes type
T848 43-51 NN denotes receptor
T847 33-42 NN denotes chemokine
T846 29-32 NNP denotes C-C
T845 26-28 IN denotes of
T844 16-25 NN denotes relevance
R446 T841 T842 aux To,evaluate
R448 T843 T844 det the,relevance
R449 T844 T842 dobj relevance,evaluate
R450 T845 T844 prep of,relevance
R451 T846 T849 compound C-C,type
R452 T847 T848 compound chemokine,receptor
R453 T848 T849 compound receptor,type
R454 T849 T845 pobj type,of
R455 T850 T849 nummod 5,type
R456 T851 T852 punct (,CCR5
R457 T852 T849 appos CCR5,type
R458 T853 T852 punct ),CCR5
R459 T854 T852 conj expression,CCR5
R460 T855 T854 cc and,expression
R461 T856 T857 compound tumor,development
R462 T857 T854 conj development,expression
R463 T858 T860 punct ",",compared
R464 T859 T860 nsubj we,compared
R465 T860 T860 ROOT compared,compared
R466 T861 T862 compound melanoma,growth
R467 T862 T860 dobj growth,compared
R468 T863 T862 prep in,growth
R469 T864 T865 nummod CCR5,knockout
R470 T865 T863 pobj knockout,in
R471 T866 T865 punct (,knockout
R472 T867 T868 nummod CCR5,−
R473 T868 T870 nummod −,−
R474 T869 T870 compound /,−
R475 T870 T865 appos −,knockout
R476 T871 T865 punct ),knockout
R477 T872 T863 pobj mice,in
R478 T873 T872 cc and,mice
R479 T874 T875 amod wild,type
R480 T875 T872 conj type,mice
R481 T876 T880 punct (,+
R482 T877 T880 nummod CCR5,+
R483 T878 T880 nummod +,+
R484 T879 T880 compound /,+
R485 T880 T875 appos +,type
R486 T881 T880 punct ),+
R487 T882 T875 conj mice,type
R488 T883 T860 punct .,compared
R489 T884 T888 nummod CCR5,mice
R490 T885 T888 nummod −,mice
R491 T886 T888 compound /,mice
R492 T887 T888 compound −,mice
R493 T888 T889 nsubj mice,showed
R494 T889 T889 ROOT showed,showed
R495 T890 T892 amod reduced,volume
R496 T891 T892 compound tumor,volume
R497 T892 T889 dobj volume,showed
R498 T893 T892 punct ",",volume
R499 T894 T895 compound tumor,weight
R500 T895 T892 conj weight,volume
R501 T896 T889 punct ",",showed
R502 T897 T889 cc and,showed
R503 T898 T900 amod increased,rate
R504 T899 T900 compound survival,rate
R505 T900 T902 dobj rate,compared
R506 T901 T902 advmod when,compared
R507 T902 T889 conj compared,showed
R508 T903 T902 prep to,compared
R509 T904 T908 nummod CCR5,mice
R510 T905 T908 nummod +,mice
R511 T906 T908 compound /,mice
R512 T907 T908 compound +,mice
R513 T908 T903 pobj mice,to
R514 T909 T889 punct .,showed
R515 T910 T911 nsubj We,investigated
R516 T911 T911 ROOT investigated,investigated
R517 T912 T913 det the,activation
R518 T913 T911 dobj activation,investigated
R519 T914 T913 prep of,activation
R520 T915 T914 pobj NF-κB,of
R521 T916 T918 mark since,is
R522 T917 T918 nsubj it,is
R523 T918 T911 advcl is,investigated
R524 T919 T922 det an,factor
R525 T920 T922 amod implicated,factor
R526 T921 T922 compound transcription,factor
R527 T922 T918 attr factor,is
R528 T923 T922 prep in,factor
R529 T924 T925 det the,regulation
R530 T925 T923 pobj regulation,in
R531 T926 T925 prep of,regulation
R532 T927 T926 pobj genes,of
R533 T928 T927 acl involving,genes
R534 T929 T930 compound cell,growth
R535 T930 T928 dobj growth,involving
R536 T931 T930 punct ",",growth
R537 T932 T930 conj apoptosis,growth
R538 T933 T932 punct ",",apoptosis
R539 T934 T932 cc and,apoptosis
R540 T935 T936 compound tumor,growth
R541 T936 T932 conj growth,apoptosis
R542 T937 T911 punct .,investigated
R543 T938 T939 amod Significant,inhibition
R544 T939 T964 nsubjpass inhibition,found
R545 T940 T939 prep of,inhibition
R546 T941 T940 pobj DNA,of
R547 T942 T943 amod binding,activity
R548 T943 T939 conj activity,inhibition
R549 T944 T943 prep of,activity
R550 T945 T944 pobj NF-κB,of
R551 T946 T943 punct ",",activity
R552 T947 T943 cc and,activity
R553 T948 T943 conj translocation,activity
R554 T949 T948 prep of,translocation
R555 T950 T949 pobj p50,of
R556 T951 T950 cc and,p50
R557 T952 T950 conj p65,p50
R558 T953 T939 prep into,inhibition
R559 T954 T955 det the,nucleus
R560 T955 T953 pobj nucleus,into
R561 T956 T939 prep through,inhibition
R562 T957 T958 det the,inhibition
R563 T958 T956 pobj inhibition,through
R564 T959 T958 prep of,inhibition
R565 T960 T959 pobj phosphorylation,of
R566 T961 T960 prep of,phosphorylation
R567 T962 T961 pobj IκB,of
R568 T963 T964 auxpass was,found
R569 T964 T964 ROOT found,found
R570 T965 T964 prep in,found
R571 T966 T968 det the,tissues
R572 T967 T968 compound melanoma,tissues
R573 T968 T965 pobj tissues,in
R574 T969 T968 prep of,tissues
R575 T970 T974 nummod CCR5,mice
R576 T971 T974 nummod −,mice
R577 T972 T974 compound /,mice
R578 T973 T974 compound −,mice
R579 T974 T969 pobj mice,of
R580 T975 T964 prep compared,found
R581 T976 T975 prep to,compared
R582 T977 T978 compound melanoma,tissues
R583 T978 T976 pobj tissues,to
R584 T979 T978 prep of,tissues
R585 T980 T984 nummod CCR5,mice
R586 T981 T984 nummod +,mice
R587 T982 T984 amod /,mice
R588 T983 T984 amod +,mice
R589 T984 T979 pobj mice,of
R590 T985 T964 punct .,found
R591 T986 T987 amod NF-κB,target
R592 T987 T1004 nsubjpass target,elevated
R593 T988 T990 amod apoptotic,expression
R594 T989 T990 compound protein,expression
R595 T990 T987 appos expression,target
R596 T991 T987 punct ",",target
R597 T992 T993 amod such,as
R598 T993 T987 prep as,target
R599 T994 T1004 nsubjpass cleaved,elevated
R600 T995 T1004 nsubjpass caspase-3,elevated
R601 T996 T998 punct ",",PARP
R602 T997 T998 compound cleaved,PARP
R603 T998 T995 appos PARP,caspase-3
R604 T999 T998 punct ",",PARP
R605 T1000 T998 cc and,PARP
R606 T1001 T998 conj Bax,PARP
R607 T1002 T1004 punct ",",elevated
R608 T1003 T1004 auxpass was,elevated
R609 T1004 T1004 ROOT elevated,elevated
R610 T1005 T1004 punct ",",elevated
R611 T1006 T1020 mark whereas,decreased
R612 T1007 T1011 det the,levels
R613 T1008 T1009 compound survival,protein
R614 T1009 T1011 compound protein,levels
R615 T1010 T1011 compound expression,levels
R616 T1011 T1020 nsubjpass levels,decreased
R617 T1012 T1011 punct ",",levels
R618 T1013 T1014 amod such,as
R619 T1014 T1011 prep as,levels
R620 T1015 T1014 pobj Bcl-2,as
R621 T1016 T1015 punct ",",Bcl-2
R622 T1017 T1015 conj C-IAP1,Bcl-2
R623 T1018 T1020 punct ",",decreased
R624 T1019 T1020 auxpass was,decreased
R625 T1020 T1004 advcl decreased,elevated
R626 T1021 T1020 prep in,decreased
R627 T1022 T1024 det the,tissues
R628 T1130 T1129 pobj NF-κB,of
R629 T1023 T1024 compound melanoma,tissues
R630 T1024 T1021 pobj tissues,in
R631 T1025 T1024 prep of,tissues
R632 T1026 T1030 nummod CCR5,mice
R633 T1027 T1030 nummod −,mice
R634 T1028 T1030 nmod /,mice
R635 T1029 T1030 compound −,mice
R636 T1030 T1025 pobj mice,of
R637 T1031 T1004 punct .,elevated
R638 T1032 T1035 advmod Interestingly,found
R639 T1033 T1035 punct ",",found
R640 T1034 T1035 nsubj we,found
R641 T1035 T1035 ROOT found,found
R642 T1036 T1050 mark that,elevated
R643 T1037 T1038 det the,level
R644 T1038 T1050 nsubjpass level,elevated
R645 T1039 T1038 prep of,level
R646 T1040 T1039 pobj IL-1Ra,of
R647 T1041 T1040 punct ",",IL-1Ra
R648 T1042 T1044 det a,growth
R649 T1043 T1044 compound tumor,growth
R650 T1044 T1040 appos growth,IL-1Ra
R651 T1045 T1046 amod suppressive,cytokine
R652 T1046 T1044 appos cytokine,growth
R653 T1047 T1050 punct ",",elevated
R654 T1048 T1050 auxpass was,elevated
R655 T1049 T1050 advmod significantly,elevated
R656 T1050 T1035 ccomp elevated,found
R657 T1051 T1050 prep in,elevated
R658 T1052 T1053 compound tumor,tissue
R659 T1053 T1051 pobj tissue,in
R660 T1054 T1053 cc and,tissue
R661 T1055 T1053 conj spleen,tissue
R662 T1056 T1055 prep of,spleen
R663 T1057 T1061 nummod CCR5,mice
R664 T1058 T1061 nummod −,mice
R665 T1059 T1061 compound /,mice
R666 T1060 T1061 compound −,mice
R667 T1061 T1056 pobj mice,of
R668 T1062 T1050 prep compared,elevated
R669 T1063 T1062 prep to,compared
R670 T1064 T1065 det the,level
R671 T1065 T1063 pobj level,to
R672 T1066 T1065 prep in,level
R673 T1067 T1071 nummod CCR5,mice
R674 T1068 T1071 nummod +,mice
R675 T1069 T1071 compound /,mice
R676 T1070 T1071 compound +,mice
R677 T1071 T1066 pobj mice,in
R678 T1072 T1035 punct .,found
R679 T1073 T1090 advmod Moreover,increased
R680 T1074 T1084 punct ",",+
R681 T1075 T1084 nsubj infiltration,+
R682 T1076 T1075 prep of,infiltration
R683 T1077 T1081 nummod CD8,cell
R684 T1078 T1081 nummod +,cell
R685 T1079 T1081 amod cytotoxic,cell
R686 T1080 T1081 compound T,cell
R687 T1081 T1076 pobj cell,of
R688 T1082 T1081 cc and,cell
R689 T1083 T1084 nmod CD57,+
R690 T1084 T1090 mark +,increased
R691 T1085 T1087 amod natural,cells
R692 T1086 T1087 compound killer,cells
R693 T1087 T1090 nsubjpass cells,increased
R694 T1131 T1130 cc and,NF-κB
R695 T1088 T1090 auxpass was,increased
R696 T1089 T1090 advmod significantly,increased
R697 T1090 T1090 ROOT increased,increased
R698 T1091 T1090 prep in,increased
R699 T1132 T1128 conj upregulation,inhibition
R700 T1092 T1093 compound melanoma,tumor
R701 T1093 T1091 pobj tumor,in
R702 T1094 T1093 cc and,tumor
R703 T1133 T1128 prep of,inhibition
R704 T1095 T1096 compound spleen,tissue
R705 T1096 T1093 conj tissue,tumor
R706 T1097 T1096 prep of,tissue
R707 T1098 T1102 nummod CCR5,mice
R708 T1099 T1102 nummod −,mice
R709 T1100 T1102 compound /,mice
R710 T1134 T1133 pobj IL-1Ra,of
R711 T1101 T1102 compound −,mice
R712 T1102 T1097 pobj mice,of
R713 T1103 T1090 prep compared,increased
R714 T1104 T1103 prep to,compared
R715 T1135 T1117 punct .,showed
R716 T1105 T1104 pobj that,to
R717 T1106 T1105 prep of,that
R718 T1107 T1111 nummod CCR5,mice
R719 T1108 T1111 nummod +,mice
R720 T1109 T1111 compound /,mice
R721 T1110 T1111 compound +,mice
R722 T1111 T1106 pobj mice,of
R723 T1112 T1090 punct .,increased
R724 T1113 T1117 advmod Therefore,showed
R725 T1114 T1117 punct ",",showed
R726 T1115 T1116 det these,results
R727 T1116 T1117 nsubj results,showed
R728 T1117 T1117 ROOT showed,showed
R729 T1118 T1121 mark that,caused
R730 T1119 T1120 amod CCR5,deficiency
R731 T1120 T1121 nsubj deficiency,caused
R732 T1121 T1117 ccomp caused,showed
R733 T1122 T1124 amod apoptotic,death
R734 T1123 T1124 compound cell,death
R735 T1124 T1121 dobj death,caused
R736 T1125 T1124 prep of,death
R737 T1126 T1125 pobj melanoma,of
R738 T1127 T1121 prep through,caused
R739 T1128 T1127 pobj inhibition,through
R740 T1129 T1128 prep of,inhibition

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T653 291-295 Protein denotes CCR5
T652 66-76 Gene_expression denotes expression
T651 66-76 Gene_expression denotes expression
T650 131-135 Protein denotes CCR5
T649 60-64 Protein denotes CCR5
T648 29-58 Protein denotes C-C chemokine receptor type 5
T693 1446-1456 Negative_regulation denotes inhibition
T692 1470-1482 Positive_regulation denotes upregulation
T691 1446-1456 Negative_regulation denotes inhibition
T690 1387-1397 Negative_regulation denotes deficiency
T689 1486-1492 Protein denotes IL-1Ra
T688 1460-1465 Protein denotes NF-κB
T687 1382-1386 Protein denotes CCR5
T686 1331-1335 Protein denotes CCR5
T685 1204-1209 Protein denotes CD57+
T684 1178-1181 Protein denotes CD8
T683 1061-1069 Positive_regulation denotes elevated
T682 1138-1142 Protein denotes CCR5
T681 998-1004 Protein denotes IL-1Ra
T680 905-914 Negative_regulation denotes decreased
T679 859-869 Gene_expression denotes expression
T678 820-828 Positive_regulation denotes elevated
T677 820-828 Positive_regulation denotes elevated
T676 754-764 Gene_expression denotes expression
T675 754-764 Gene_expression denotes expression
T674 886-899 Protein denotes Bcl-2, C-IAP1
T673 811-814 Protein denotes Bax
T672 801-805 Protein denotes PARP
T671 723-728 Protein denotes NF-κB
T670 483-493 Negative_regulation denotes inhibition
T669 483-493 Negative_regulation denotes inhibition
T668 590-600 Negative_regulation denotes inhibition
T667 590-600 Negative_regulation denotes inhibition
T666 590-600 Negative_regulation denotes inhibition
T665 532-545 Localization denotes translocation
T664 532-545 Localization denotes translocation
T663 483-493 Negative_regulation denotes inhibition
T662 604-619 Phosphorylation denotes phosphorylation
T661 570-577 Entity denotes nucleus
T660 501-508 Binding denotes binding
T659 623-626 Protein denotes IκB
T658 557-560 Protein denotes p65
T657 549-552 Protein denotes p50
T656 521-526 Protein denotes NF-κB
T655 325-335 Positive_regulation denotes activation
T654 339-344 Protein denotes NF-κB
R349 T648 T651 themeOf C-C chemokine receptor type 5,expression
R350 T649 T652 themeOf CCR5,expression
R351 T654 T655 themeOf NF-κB,activation
R352 T656 T660 themeOf NF-κB,binding
R353 T657 T664 themeOf p50,translocation
R354 T658 T665 themeOf p65,translocation
R355 T659 T662 themeOf IκB,phosphorylation
R356 T660 T663 themeOf binding,inhibition
R357 T661 T664 locationOf nucleus,translocation
R358 T661 T665 locationOf nucleus,translocation
R359 T662 T668 themeOf phosphorylation,inhibition
R360 T664 T666 themeOf translocation,inhibition
R361 T664 T669 themeOf translocation,inhibition
R362 T665 T667 themeOf translocation,inhibition
R363 T665 T670 themeOf translocation,inhibition
R364 T671 T675 themeOf NF-κB,expression
R365 T673 T676 themeOf Bax,expression
R366 T674 T679 themeOf "Bcl-2, C-IAP1",expression
R367 T675 T677 themeOf expression,elevated
R368 T676 T678 themeOf expression,elevated
R369 T679 T680 themeOf expression,decreased
R370 T681 T683 themeOf IL-1Ra,elevated
R371 T687 T690 themeOf CCR5,deficiency
R372 T688 T691 themeOf NF-κB,inhibition
R373 T689 T692 themeOf IL-1Ra,upregulation
R374 T690 T691 causeOf deficiency,inhibition
R375 T690 T693 causeOf deficiency,inhibition
R376 T692 T693 themeOf upregulation,inhibition